Companies → CSL Behring L.L.C.
CSL Behring L.L.C.
United States, Pennsylvania, King Of Prussia
Updated Jul 18, 2024 10:29
Description
CSL Behring is a global leader in developing and delivering high-quality medicines that treat people with rare and serious diseases. Its treatments offer promise for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. CSL Behring operates CSL Plasma, one of the world's largest plasma collection networks. The company uses three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients' lead full lives. The company is a subsidiary of Australia's CSL Limited.
Address:
1020 1ST Ave King OF Prussia
PA
19406-1310 United States
Website:
Revenue
$1759.36M
Company is likely to buy
- Plasma for fractionation
- Alpha-1 proteinase inhibitor
- C1 esterase inhibitor
- Fibrinogen concentrate
- Factor ix concentrate
- Factor viia concentrate
- Factor xiii concentrate
- Von willebrand factor concentrate
- Plasma-derived therapies
- Monoclonal antibodies
- Cytokines
- Interferons
- Enzyme replacement therapies
- Hematopoietic stem cell transplantation products
- Recombinant protein production systems
- Cell therapy products
- Gene therapy products
- Recombinant factor viii
- Recombinant coagulation factors
- Immunoglobulins
- Albumin
- Hemophilia treatment drugs
- Antithrombin iii
- Cardiovascular disease medications
- Metabolic disorder medications
- Respiratory disease medications
- Transplant rejection medications
- Plasma collection equipment
Company is likely to sell
- Plasma-derived medicines
- Recombinant proteins for hematology
- Immunoglobulin for immunology conditions
- Hepatitis b immunoglobulin for hepatitis b treatment
- Tetanus immunoglobulin for tetanus prevention
- Rabies immunoglobulin for rabies treatment
- Varicella-zoster immunoglobulin for varicella-zoster treatment
- Measles immunoglobulin for measles treatment
- Rubella immunoglobulin for rubella treatment
- Mumps immunoglobulin for mumps treatment
- Pneumococcal vaccine for pneumonia prevention
- Influenza vaccine for influenza prevention
- Hepatitis b vaccine for hepatitis b prevention
- Tetanus vaccine for tetanus prevention
- Diphtheria vaccine for diphtheria prevention
- Pertussis vaccine for pertussis prevention
- Polio vaccine for polio prevention
- Rotavirus vaccine for rotavirus prevention
- Meningococcal vaccine for meningococcal prevention
- Hemophilus influenzae type b vaccine for hib prevention
- Albumin for respiratory diseases
- Cell therapy for cardiovascular diseases
- Gene therapy for metabolic disorders
- C1 esterase inhibitor for hereditary angioedema
- Fibrinogen concentrate for bleeding disorders
- Alpha-1 proteinase inhibitor for alpha-1 antitrypsin deficiency
- Von willebrand factor for von willebrand disease
- Factor viii for hemophilia treatment
- Antithrombin for thrombosis prevention
Disclaimer:
IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.